These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34538108)

  • 1. Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration/perfusion.
    Raphaëlle P; Elodie P; Nathalie J; Odile A; Paul S; Isabelle M; Hélène L
    J Vasc Access; 2023 Jul; 24(4):653-659. PubMed ID: 34538108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.
    Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
    Harrison BR; Peters BG; Bing MR
    Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37159242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.
    Sessink PJ; Connor TH; Jorgenson JA; Tyler TG
    J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study.
    Simon N; Vasseur M; Pinturaud M; Soichot M; Richeval C; Humbert L; Lebecque M; Sidikou O; Barthelemy C; Bonnabry P; Allorge D; Décaudin B; Odou P
    PLoS One; 2016; 11(7):e0159052. PubMed ID: 27391697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a closed-system drug transfer device reduces contamination with doxorubicin during bolus injection.
    Marler-Hausen T; Holt C; Headley C; Sessink P
    Br J Nurs; 2020 May; 29(10):S15-S21. PubMed ID: 32463759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.
    Valero S; López-Briz E; Vila N; Solana A; Melero M; Poveda JL
    Regul Toxicol Pharmacol; 2018 Jun; 95():1-7. PubMed ID: 29510165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator.
    Vyas N; Turner A; Clark JM; Sewell GJ
    J Oncol Pharm Pract; 2016 Feb; 22(1):10-9. PubMed ID: 25073678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a safe infusion device on reducing occupational exposure of nurses to antineoplastic drugs: a comparative prospective study. Contamoins-1.
    Forges F; Blanc E; Raymond B; Menguy S; Macé A; Hugues M; Macron C; Bouleftour W; Tinquaut F; Guitton J; Simoëns X
    Int Arch Occup Environ Health; 2021 Aug; 94(6):1317-1325. PubMed ID: 33733326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleaning Efficiencies of Three Cleaning Agents on Four Different Surfaces after Contamination by Gemcitabine and 5-fluorouracile.
    Böhlandt A; Groeneveld S; Fischer E; Schierl R
    J Occup Environ Hyg; 2015; 12(6):384-92. PubMed ID: 25751496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastomeric pump reliability in postoperative regional anesthesia: a survey of 430 consecutive devices.
    Remerand F; Vuitton AS; Palud M; Buchet S; Pourrat X; Baud A; Laffon M; Fusciardi J
    Anesth Analg; 2008 Dec; 107(6):2079-84. PubMed ID: 19020162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.